In the month of February 2009, Andrew Witty revealed his vision for big pharma as a trigger for change which focused on two key problems: 1) promoting innovation for the products that treat or prevent neglected tropical diseases and 2) enhancing access to medications in the world's poorest countries. He had announced the development of the "Pharmaceutical Patent Pool" and wondered if it was the correct strategy to present on the two crucial issues.
PUBLICATION DATE: March 08, 2011 PRODUCT #: W10017-HCB-ENG
This is just an excerpt. This case is about STRATEGY & EXECUTION
Related Case Solutions & Analyses:
Employee Handbook
McDonald’s Twitter Campaign: Hype Versus Reality
Kent Chemical: Organizing for International Growth
Global Wine War 2015: New World Versus Old
Lilliputian Systems
Venture Capital Deal Sourcing and Screening
Crocs (C): Back from the Dead
France Telecom-Orange in 2011, Stéphane Richard and “Conquests 2015”
The Rise of the Regional Sports Network Content Ownership in an Ever-Changing World: The YES Network in 2009
Water Funds: Financing Nature’s Ability to Protect Water Supplies
